A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...
Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...
Add Yahoo as a preferred source to see more of our stories on Google. With more people turning to popular weight-loss medications, questions about potential side effects are increasing — and some ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...
Weight loss jabs have become increasingly popular in recent years, with celebrities and everyday workers alike trying them ...
The little blue pill that revolutionized bedroom performance comes with potential risks that extend far beyond its intended target area. While Viagra helps millions of men overcome erectile ...
Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...
Transient vision loss is temporary vision loss lasting from seconds to less than 24 hours that can affect one or both eyes. It can indicate vascular health conditions, including an impending stroke.
A study links semaglutide -- the ingredient in Ozempic -- with a condition that causes vision loss. Here's what we know about semaglutide and eye health. Jessica was a writer on the Wellness team, ...
BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.
Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...